CIS
Capital International Sarl’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-19,565
| Closed | -$810K | – | 211 |
|
|
2022
Q3 | $810K | Buy |
19,565
+2,035
| +12% | +$84.3K | 0.07% | 193 |
|
|
2022
Q2 | $1.05M | Buy |
17,530
+1,446
| +9% | +$86.3K | 0.08% | 185 |
|
|
2022
Q1 | $1.17M | Sell |
16,084
-18,722
| -54% | -$1.36M | 0.06% | 222 |
|
|
2021
Q4 | $2.93M | Buy |
34,806
+25,930
| +292% | +$2.18M | 0.14% | 158 |
|
|
2021
Q3 | $801K | Sell |
8,876
-1,349
| -13% | -$122K | 0.07% | 181 |
|
|
2021
Q2 | $975K | Sell |
10,225
-109
| -1% | -$10.4K | 0.08% | 177 |
|
|
2021
Q1 | $1.18M | Sell |
10,334
-1,608
| -13% | -$183K | 0.11% | 161 |
|
|
2020
Q4 | $1.65M | Buy |
11,942
+730
| +7% | +$101K | 0.17% | 125 |
|
|
2020
Q3 | $922K | Buy |
11,212
+463
| +4% | +$38.1K | 0.11% | 146 |
|
|
2020
Q2 | $841K | Buy |
10,749
+1,659
| +18% | +$130K | 0.11% | 149 |
|
|
2020
Q1 | $404K | Sell |
9,090
-32,159
| -78% | -$1.43M | 0.07% | 155 |
|
|
2019
Q4 | $1.76M | Buy |
41,249
+4,049
| +11% | +$173K | 0.27% | 101 |
|
|
2019
Q3 | $1.59M | Sell |
37,200
-14,800
| -28% | -$633K | 0.27% | 102 |
|
|
2019
Q2 | $3.3M | Sell |
52,000
-21,300
| -29% | -$1.35M | 0.46% | 68 |
|
|
2019
Q1 | $5.08M | Buy |
73,300
+2,200
| +3% | +$153K | 0.64% | 52 |
|
|
2018
Q4 | $3.09M | Sell |
71,100
-11,900
| -14% | -$517K | 0.37% | 82 |
|
|
2018
Q3 | $6.34M | Buy |
83,000
+17,100
| +26% | +$1.31M | 0.6% | 54 |
|
|
2018
Q2 | $5.07M | Sell |
65,900
-40,950
| -38% | -$3.15M | 0.51% | 57 |
|
|
2018
Q1 | $5.45M | Hold |
106,850
| – | – | 0.52% | 56 |
|
|
2017
Q4 | $4.96M | Sell |
106,850
-21,470
| -17% | -$996K | 0.46% | 62 |
|
|
2017
Q3 | $6.83M | Buy |
128,320
+4,000
| +3% | +$213K | 0.57% | 58 |
|
|
2017
Q2 | $7.72M | Buy |
124,320
+16,870
| +16% | +$1.05M | 0.67% | 49 |
|
|
2017
Q1 | $7.28M | Buy |
107,450
+16,700
| +18% | +$1.13M | 0.63% | 52 |
|
|
2016
Q4 | $6.38M | Buy |
90,750
+5,500
| +6% | +$387K | 0.59% | 58 |
|
|
2016
Q3 | $6.05M | Buy |
+85,250
| New | +$6.05M | 0.51% | 66 |
|